nasdaq-nms:srpt
SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit |
SAN DIEGO, July 1, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or … SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit |Read more